Evidence map›Paper›PMID 32734391›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2021

Acute palliative care unit-initiated interventions for advanced cancer patients at the end of life: prediction of impending death based on Glasgow Prognostic Score.

Yoshihide Nagasako, Masahiro Suzuki, Tetsuji Iriyama, Yoko Nagasawa, Yoshiki Katayama, Kaori Masuda

Abstract read
PubMed Publisher
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Prognostication of the Last Days of Life.Cancer research and treatment · 2022
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yoshihide NagasakoDepartment of Internal Medicine, Ichikawa Higashi Hospital, 2-14-3, Futamata, Ichikawa, 272-0001, Chiba, Japan. sako.yoshihide@nifty.com.ORCID https://orcid.org/0000-0002-1126-615X
Masahiro SuzukiDepartment of Palliative Medicine, NTT Medical Center Tokyo, Tokyo, Japan.
Tetsuji IriyamaDepartment of Palliative Medicine, NTT Medical Center Tokyo, Tokyo, Japan.
Yoko NagasawaDepartment of Palliative Medicine, NTT Medical Center Tokyo, Tokyo, Japan.
Yoshiki KatayamaDepartment of Palliative Medicine, NTT Medical Center Tokyo, Tokyo, Japan.
Kaori MasudaDepartment of Palliative Medicine, NTT Medical Center Tokyo, Tokyo, Japan.
NTT Medical Center · JPIchikawa City Rehabilitation Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeUnexpected death occurred in an unexpectedly high proportion of advanced cancer patients in the acute palliative care unit (APCU) setting and associated with fewer signs of impending death. Recognition of patients at high risk of approaching death, especially immediately after admitting APCU among clinicians, can improve the end-of-life trajectory. Our objective was accurate prognostication within a few days of admission.

methodsPatients admitted to an APCU of the NTT Medical Center Tokyo, Tokyo, Japan, between April 2009 and December 2016 were retrospectively examined. The Glasgow Prognostic Score (GPS) was optimized with concomitant neutrophilia, lymphocytopenia, thrombocytopenia, anemia, and monocytosis. Kaplan-Meier survival curves were estimated, and independent predictors for 3-day mortality were identified using univariate and multivariate analyses. The sensitivity, specificity, and likelihood ratios (LRs) associated with imminent death were also assessed.

resultsNine hundred ninety-one patients were included; 52.9% was male. The median age was 72 years. The median survival was 13 days (IQ range 6 to 26), and 11.7% died within 3 days of admission. Significant difference in survival with a GPS of 2 was observed in GPS optimized with concomitant thrombocytopenia, and it was the only significant predictor associated with 3-day mortality (p = 0.004), which had high specificity (> 95%) and high positive LR (> 5).

conclusionThe prognostic value of the GPS was enhanced by adding thrombocytopenia. The concurrent use of the GPS and platelet count improved the prognostication of limited time of survival and could assist in the personal and clinical decisions for advanced cancer patients.

Indexed as

DeathAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedMultivariate AnalysisNeoplasmsPalliative CarePrognosisRetrospective StudiesAcute palliative care unitGlasgow Prognostic ScorePalliative carePrognosticationThrombocytopenia

Identifiers

PMID32734391
OpenAlexW3046133938

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.